EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Enhancing co-stimulation of CAR T cells to improve treatment outcomes in solid cancers

Aaron J Harrison iD, Xin Du, Bianca von Scheidt, Michael H Kershaw, Clare Y Slaney

Immunotherapy Advances · 01.01.2021 · 1 (1)

DOI: 10.1093/immadv/ltab016 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunotherapy Advances, online erschienen am 31.07.2021. Verfasst von Aaron J Harrison und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Immunology Program, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Health and Medical Research Council of Australia, National Breast Cancer Foundation of Australia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Co-stimulation is a fundamental component of T cell biology and plays a key role in determining the quality of T cell proliferation, differentiation, and memory formation. T cell-based immunotherapies, such as chimeric antigen receptor (CAR) T cell immunotherapy, are no exception. Solid tumours have largely been refractory to CAR T cell therapy owing to an immunosuppressive microenvironment which limits CAR T cell persistence and effector function. In order to eradicate solid cancers, increasingly sophisticated strategies are being developed to deliver these vital co-stimulatory signals to CAR T cells, often specifically within the tumour microenvironment. These include designing novel co-stimulatory domains within the CAR or other synthetic receptors, arming CAR T cells with cytokines or using CAR T cells in combination with agonist antibodies. This review discusses the evolving role of co-stimulation in CAR T cell therapies and the strategies employed to target co-stimulatory pathways in CAR T cells, with a view to improve responses in solid tumours.

Schlagwörter

Stichwörter der Autor:innen

T cell immunologychimeric antigen receptorco-stimulationimmunotherapy

Autor:innen und Institutionen

  • Cancer Immunology Program, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.
  • Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.

ORCID-Profile: Aaron J Harrison

Förderung

  • National Health and Medical Research Council of Australia
  • National Breast Cancer Foundation of Australia

Zitieren

APA

Harrison, A. J., Du, X., von Scheidt, B., Kershaw, M. H., & Slaney, C. Y. (2021). Enhancing co-stimulation of CAR T cells to improve treatment outcomes in solid cancers. Immunotherapy Advances, 1(1). https://doi.org/10.1093/immadv/ltab016

Vancouver

Harrison AJ, Du X, von Scheidt B, Kershaw MH, Slaney CY. Enhancing co-stimulation of CAR T cells to improve treatment outcomes in solid cancers. Immunotherapy Advances. 2021;1(1). doi:10.1093/immadv/ltab016

BibTeX
@article{Harrison2021,
  author = {Harrison, Aaron J and Du, Xin and von Scheidt, Bianca and Kershaw, Michael H and Slaney, Clare Y},
  title = {Enhancing co-stimulation of CAR T cells to improve treatment outcomes in solid cancers},
  journal = {Immunotherapy Advances},
  year = {2021},
  volume = {1},
  number = {1},
  doi = {10.1093/immadv/ltab016}
}
Kostenlos starten →